Furthermore, in line with its suggested role in cancer cell stemness [5], DNMT3B targeting also strongly reduced MM cell clonogenic outgrowth, which is the ability of a single cell to grow out into a colony. The gene discussed is DNMT3B; the disease is Miyoshi myopathy.